Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.6 CHF | -1.34% | +2.27% | +15.01% |
Jun. 20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
Jun. 20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Trading Ideas